1MANZINI P,GIROTTO M, BORSOTTI R, et al. I- talian blood donors with anti-HBc nd occult hepatitis B virus infection[J]. Haematologica, 2007,92 .. 1664 -- 1670.
2BROJER E, GRABARCZYK P, LISZEWSKI C, et al.Characterization of HBV DAN +/HBsAg-blood do- nors in Poland identified by triplex NAT[J]. Hepatol- ogy,2006,44:1666-- 1674.
3KATSOULIDOU A, PARASKEVIS D, MAGIORKI- NIS E,et al. Molecular characterization of occult hep- atitis B cases in Greek blood donors[J]. J Med Virol, 2009,81:815--825.
6LEVICNIK-STEZINAR S, RAHNE-POTOKAR V, CANDOTTI D,et al. Anti-HBspositive occult hepati- tis B virus carrier blood infections in two transfusion recipients[J] J Hepatol, 2008,48 : 1022-- 1027.
7SATAKE M,TAIRA R,YUGI H. et al. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookbaek program [J]. Transfu- sion,2007,47:1197 1205.
8URBANI S'; FAGNONI F, MISSALE G, et al. The role of anti-core antibody response in the detection of occult hep-atitis B virus infection[J]. Clin Chem Lab Med,2010,48 ..23--29.
9VITALE F, TRAMUTO F, QRLANDO A, et al. Can the serological status of anti-HBc alone be considered a sentinel marker for detection of occult HBV infec- tion [J]. J Men Virol,2008,80:577--582.
6Giacoia GP, Kas, prisin DO. Transfusion acquired hepatitis A [J]. South Med J, 1989,82( 11 ):1357-1360.
7Arnold DM, Neame PB, Meyer RM, et al. Autologous peripheral blood progenitor cells are a potential source of parvovirus B19 infection [ J ]. Transfusion, 2005,45 ( 3 ) :394-398.
8Biggerstaff BJ, Peterson LR. Estimated risk of transmission of West Nile Virus through blood transfusion in the US, 2002 [J]. Transfusion, 2003, 43 ( 8 ): 1007-1017.
9Busch MP, Glynn SA, Stramer SL, Strong DM, Caglipti S, Wright D J, et al. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection recently infected donors[J]. Transfusion,2005,45(2):254-264.
10Winslow RM, Intaglietta M. Red cell age and loss of function: advance or SNO-job?[J].Transfusion,2008,48(3):411-414.
